Back to results
US 12,746,269 B2Granted
Cyclic peptide compounds and methods of use
AssigneesFengqiao Li, Michael Peter Vitek
InventorsFengqiao Li, Michael Peter Vitek, Yuchen Chen
Life of this patent
Estimating the term…
Abstract
Cyclic peptide compounds are provided having the general formula (I) shown below. The cyclic peptide compounds are also provided for use in the preparation of a pharmaceutical composition for preventing and/or treating stroke, and related conditions or diseases. Experimental data indicate that the cyclic peptide compounds can have a preventive and/or therapeutic effect on stroke, and related conditions/diseases.
Claims10
A cyclic peptide compound having the general formula (I):
- wherein:
- X3 is Cys, Glu, Asp, Lys, Orn, 2,4-Diaminobutyric Acid (Dab), 2,3-Diaminopropionic Acid (Dap), Ser, Gln, or halogenated alanine, or their corresponding enantiomeric D-amino acids;
- X13 is Cys, Glu, Asp, Lys, Orn, Dab, Dap, Ser, Gln, or halogenated alanine, or their corresponding enantiomeric D-amino acids;
- X8 is Aib;
- The symbol “” represents a chemical bond between X3 and X13, wherein the chemical bond is selected from:
- —SS—, —CH2—S—CH2—, —CO—NH—, —CO—O—, —CH2—NH—, —(CH2)n (n=2-15), or —(CH2)n-CH═CH—(CH2)n (n=2-15);
- or
- —S—(CH2)n-R1—(CH2)n-S—, wherein R1 is a hydrocarbon group, an aryl group or a heteroaryl group, n=1-3;
- Y1 is present or absent, and when present, Y1 is R2—CO—, wherein R2 is a hydrocarbon group, an aryl group, or a heteroaryl group;
- Y2 is present or absent, and when present, Y2 is a carboxy-terminal group.
7 more elements
Dependencies are inferred from the claim text.